Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

14.09
Delayed Data
As of Aug 28
 +1.00 / +7.64%
Today’s Change
2.36
Today|||52-Week Range
18.30
+392.66%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close13.09
Today’s open13.15
Day’s range13.06 - 14.09
Volume41,717
Average volume (3 months)93,133
Market cap$129.9M
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)-697.14%
Earnings growth (this year)+57.71%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.74

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.01+0.16%
AKAOAchaogen Inc+0.34+5.11%
GLYCGlycoMimetics Inc-0.03-0.42%
TNXPTonix Pharmaceutical...+0.09+1.37%
Data as of 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri A. Henwood
Treasurer, Chief Financial &
Business Officer
Charles T. Garner
Corporate headquarters
Malvern, Pennsylvania

Forecasts

Partner Offers